Health

Professional ergonomic technology, Hbada leads the new development of sedentary health

FONTANA, Calif., June 27, 2024 /PRNewswire/ -- As one of the most popular leading brands in the Ergonomic Chair industry, the Hbada E3 Ergonomic Office Chair, launched as an annual innovation product, has aroused the attention and discussion of the majority of users. The problem of sitting in th...

2024-06-27 16:11 1576

HKBN and Bowtie Collaborate to Launch an Exclusive Four-In-One Healthcare Service Plan

Enhancing the Healthcare Industry to Advance Public Well-being HONG KONG, June 27, 2024 /PRNewswire/ -- Hong Kong Broadband Network Limited (HKBN) and Bowtie Life Insurance Company (Bowtie)[1], Hong Kong's first virtual insurer, have teamed up to launch an exclusive Four-In-One Healthcare Service...

2024-06-27 14:50 1949

US FDA New Drug Application Approval of Ohtuvayre™ (ensifentrine) for the Maintenance Treatment of COPD

SHANGHAI, June 27, 2024 /PRNewswire/ -- Nuance Pharma's global partner Verona Pharma plc (Nasdaq: VRNA), announces the US Food and Drug Administration ("FDA") approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvay...

2024-06-27 13:59 2117

Amsino Medical Group announces transformational investment from Novo Tellus

POMONA, Calif., June 27, 2024 /PRNewswire/ -- Amsino Medical Group ("Amsino"), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain...

2024-06-27 12:27 1761

NSW Government extends it support for community heart health initiatives

SYDNEY, June 27, 2024 /PRNewswire/ --  The Heartbeat of Football Foundation (the Foundation) is excited to announce an additional grant of$150,000 from the NSW Government to deliver more community sport focused heart health initiatives across regional NSW sporting grounds until 2026. * The "#H...

2024-06-27 10:30 1858

Easy and Fast "Cat Urine Test Kit" for Early Detection of Kidney Disease, Gallstones, and Cystitis

BANGKOK, June 27, 2024 /PRNewswire/ -- Researchers from Chula Faculty of Science invented an easy-to-use "Cat Urine Test Kit" to screen for the risk of kidney disease, gallstones, and cystitis in cats. The test kit provides fast and accurate results, so cats can be ...

2024-06-27 10:00 2027

Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 26, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-06-27 07:08 1708

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

With the focus on improving patient experience and reducing burden on sites  PHILADELPHIA, June 27, 2024 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases, ...

2024-06-27 07:00 1626

Nutiani report reveals age-agnostic interest and proactive consumers in healthy ageing space

AUCKLAND, New Zealand, June 27, 2024 /PRNewswire/ -- Nutiani's latest Consumer Health and Nutrition Index,conducted in collaboration with Ipsos, indicates a strong and growing consumer focus on ageing healthily. This is underpinned by a strong preventive mindset (88%) and a firm awareness on the ...

2024-06-27 06:00 1918

The Future of Telehealth Relies on Seamless UC&C Monitoring

* IR launches a healthcare bundle to meet the demands of proactive communication monitoring in healthcare organizations. SYDNEY, June 26, 2024 /PRNewswire/ -- IR (ASX:IRI), a leading provider of global performance management and analytics for Unified Communications and Collaboration (UC&C), h...

2024-06-26 21:30 2103

HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002

HANGZHOU, China, June 26, 2024 /PRNewswire/ -- HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive results from Phase I clinical trials of its innovative oral small molecule GLP-1 receptor agoni...

2024-06-26 21:05 2491

TurtleTree Announces Strategic Partnership with Strive, a Sustainable Nutrition Company; Expands Consumer Product Offerings with LF+™ for Adult and Sports Nutrition

Strive and TurtleTree to Collaborate on a Immunity Support Beverage for Adults and a Protein Powder to be Made Available to the Public Q1 2025 SACRAMENTO, Calif. and SINGAPORE, June 26, 2024 /PRNewswire/ -- TurtleTree , a pioneer in sustainable nutrition, today announces ...

2024-06-26 21:01 3137

Neurophet to present brain stimulation simulation study at OHBM 2024

- Presents a poster identifying tDCS effects for patients with AD and cognitively normal people - Showcases brain imaging treatment planning software for electric brain stimulation Neurophet tESplan Plus SEOUL, South Korea, June 26, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI...

2024-06-26 21:00 1865

bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention

NEWARK, Del., June 26, 2024 /PRNewswire/ -- bioSeedin, a flourishing global licensing and consulting platform, captivated attendees as an esteemed exhibitor at the BIO International Convention, the preeminent global biotech gathering. This prestigious event unfolded inSan Diego, spanning from Jun...

2024-06-26 21:00 1230

Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau

The prospectively defined, double-blind analysis of biomarker-positive patients with mild Alzheimer's disease showed more rapid clinical progression in biomarker-positive patients, highlighting the suitability of elevated pTau for selecting patients in the on-going XanaMIA phase2b trial SYDNEY, ...

2024-06-26 20:56 2025

CARING PHARMACY UNVEILS MOM & CUTIE PRODUCT LINE IN CELEBRATORY 30TH ANNIVERSARY EVENT

KUALA LUMPUR, Malaysia, June 26, 2024 /PRNewswire/ -- CARiNG Pharmacy proudly celebrates its 30th anniversary with the grand launch of their 'Mom and Cutie' product line. To commemorate this milestone event, CARiNG Pharmacy held a Health & Beauty Carnival at 1 Utama Shopping Centre, Ground Floor ...

2024-06-26 20:49 2117

Fufang E'jiao Syrup's Breakthrough Research on Cancer-Related Fatigue Receives "Special Excellence Award" at 2024 ASCO Annual Meeting

CHICAGO, June 26, 2024 /PRNewswire/ -- The 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO), a significant event in the global oncology community, was grandly held inChicago, USA, from May 31 to June 4, 2024. ASCO has announced the list of outstanding abstracts for 2024, wh...

2024-06-26 18:42 1474

Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). - The approval of XPOVIO® by the NHIS in South Korea is the fourth national reimburse...

2024-06-26 16:44 3731

Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's First Robotic Stereotactic Radiotherapy Program

* The program will enhance the development of oncology care, thereby, advancing healthcare landscape of the region * Participants will engage in in-depth discussions and demonstrations, ensuring a robust and practical learning experience BANGALORE, India, June 26, 2024 /PRNewswire/ --  Apollo...

2024-06-26 13:53 1952

Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA

NANJING, China, June 26, 2024 /PRNewswire/ -- On June 25, 2024, Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group (2096.HK), announced that Enlituo® (generic name: cetuximab beta injection), a new generation anti-epidermal growth factor receptor (EG...

2024-06-26 12:36 1545
1 ... 64656667686970 ... 858